Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

It's Time to Buy AT&T Stock Hand Over Fist


Telecom giant AT (NYSE: T) slightly missed expectations for revenue and earnings when it reported its first-quarter results on Wednesday, but those headline figures don't tell the whole story. AT continued to win new wireless subscribers while keeping churn AT record-low levels, and its broadband business impressed.

AT produced $3.1 billion in free cash flow during Q1, and it maintained its guidance calling for between $17 billion and $18 billion in free cash flow for the full year. With the stock trading for less than 7 times the midpoint of that range, investors are getting an incredible bargain.

While overall mobility revenue was flat in the first quarter, a drop in equipment revenue was entirely to blame. Mobility services revenue jumped 3.3% year over year, driven by AT's solid subscriber gains and rising revenue per user.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.056
-0.890%
Allergy Therapeutics PLC shows a slight decrease today, losing -€0.001 (-0.890%) compared to yesterday.

Like: 0
T
Share

Comments